Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-01-30

Janux hires CMO after T cell engager deal with Bristol Myers; A batch of appointments at Lexeo

Endpoints News 2026-01-30

Reed Jobs' cancer biotech investment firm Yosemite eyes $350M fund

Endpoints News 2026-01-30

AstraZeneca pays $1.2B for CSPC's long-acting obesity drugs

Endpoints News 2026-01-29

Takeda 'anticipated' Medicare negotiations for top seller Entyvio

Endpoints News 2026-01-29

Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says

Endpoints News 2026-01-29

White House postpones planned TrumpRx launch event

Endpoints News 2026-01-29

Sanofi vows to stay committed to vaccines as portfolio takes a hit

Endpoints News 2026-01-29

The disrupted fate of pharmacy startups

Endpoints News 2026-01-29

Sanofi's pipeline cuts; Breakthru Medicine raises $60M

Endpoints News 2026-01-29

Summit gets November PDUFA date for its PD-1xVEGF bispecific

Endpoints News 2026-01-29

Trump looks to raise South Korea levies; Siegfried expands

Endpoints News 2026-01-29

Agomab anticipates $182M IPO as it builds fibrosis pipeline

Endpoints News 2026-01-29

AstraZeneca makes $15B bet on China to expand manufacturing and R&D

Endpoints News 2026-01-29

Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff

Endpoints News 2026-01-29

Flagship's Repertoire gets another autoimmune partner in Lilly

Endpoints News 2026-01-29

Tenpoint gets FDA nod for presbyopia eye drop and $235M

Endpoints News 2026-01-28

ChenMed CEO warns against GLP-1s for seniors

Endpoints News 2026-01-28

Round three of IRA negotiations is expected to be ‘manageable’ for pharma

Endpoints News 2026-01-28

Oral Rogaine maker Veradermics looks to raise $181M from IPO

Endpoints News 2026-01-28

FDA asks court to pause Louisiana's abortion pill fight

-167 / 25